[Seroprevalence of rickettsial infections of the Boutonneuse fever group or its apparent group in Bangui (Central African Republic)].
115 sera from African individuals, including 66 HIV-1-infected individuals and 49 HIV-seronegative age-matched healthy controls, living in Bangui, Central African Republic, were screened for Rickettsia conorii antibody by indirect immunofluorescent assay; 53 (46%) sera had significant IgG to R. conorii titer, and 5 (4.3%) had significant IgM to R. conorii titer, without significant difference between HIV-positive and negative individuals. These findings indicate a great exposure to spotted fever group rickettsial infections in Bangui.
Ekala
M T
MT
Laboratoire de Virologie, Hôpital Broussais, Paris, France.
Gresenguet
G
G
Belec
L
L
D000328:Adult; D000907:Antibodies, Bacterial / Q000097:blood; D001907:Boutonneuse Fever / Q000453:epidemiology* / Q000276:immunology; D016022:Case-Control Studies; D002488:Central African Republic / Q000453:epidemiology; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D015658:HIV Infections / Q000453:epidemiology; D018023:HIV Seronegativity; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D008297:Male; D015995:Prevalence; D011446:Prospective Studies; D012282:Rickettsia Infections / Q000453:epidemiology / Q000276:immunology; D016036:Seroepidemiologic Studies
D000907:Antibodies, Bacterial; D007074:Immunoglobulin G; D007075:Immunoglobulin M
Séroprévalence des infections à rickettsies du groupe des fièvres boutonneuses ou apparentées à Bangui (République centrafricaine).